Concepedia

DESTINATION: a phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the long-term safety and tolerability of tezepelumab in adults and adolescents with severe, uncontrolled asthma

Andrew Menzies‐Gow, Sandhia Ponnarambil, John Downie, Karin Bowen, Åsa Hellqvist, Gene Colice

Respiratory Research · 2020 · 65 citations · 26 references

DOIFull text

Open access

References

26

GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION

Romain Pauwels · Arerugī/Arerugi · 1996 · 10.1K citations

, , +6

Human epithelial cells trigger dendritic cell–mediated allergic inflammation by producing TSLP

Vassili Soumelis, Pedro A. Reche, Holger Kanzler et al. · Nature Immunology · 2002 · 2.1K citations

, , +13

Dupilumab in Persistent Asthma with Elevated Eosinophil Levels

Sally E. Wenzel, Linda Ford, David S. Pearlman et al. · New England Journal of Medicine · 2013 · 1.3K citations · Full text

Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma

William W. Busse, Jonathan Corren, Bobby Q. Lanier et al. · Journal of Allergy and Clinical Immunology · 2001 · 1.3K citations · Full text

, , +9

Tezepelumab in Adults with Uncontrolled Asthma

Jonathan Corren, Jane R. Parnes, Wang Liang-wei et al. · New England Journal of Medicine · 2017 · 906 citations · Full text

, , +17